3 reports

In 2015, Zarxio®(filgrastim), launched by Sandoz, became the first biosimilar approved by the US Food and Drug Administration (FDA) under the 2010 Biologics Price Competition and Innovation Act (BPCIA).

  • Clinical Trial
  • Hormone
  • Immunochemistry Test
  • Vitamin
  • Siemens Healthcare GmbH

The molecules developed by Companies in Phase II, Phase I and Preclinical stages are ##, ## and ## respectively.

  • Monoclonal Antibody
  • Ovarian Cancer
  • Vaccine
  • Vitamin
  • TapImmune Inc.
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Endocrine Disease
  • Pathology
  • Therapy
  • Vitamin
  • World